Science Explorer Interactive view Map
Company · Innsbruck · Austria

Bionorica (Austria)

bionorica.deROR OpenAlex
Research works
18
▼ 58% vs 2013–17
Citations
283
15.7 per fractional work
Top-10% rate
38.2%
record average 16.5%
Open access
21%
world 28%

Not ranked overall: Bionorica (Austria) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.44× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 1.38× its world share, 0 worksImmunology and Micro…Neuroscience: 11.02× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 21.75× its world share, 0 worksPharmacology, Toxico…Chemistry: 4.88× its world share, 0 worksChemistryHealth Professions: 1.50× its world share, 0 worksHealth ProfessionsMedicine: 2.80× its world share, 1 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 21.8×. Every wedge is a field page.

Which research topics does Bionorica (Austria) publish most on?

By volume in 2022–2025: Antibiotics Pharmacokinetics and Efficacy, Pain Mechanisms and Treatments, Peripheral Neuropathies and Disorders and Traditional and Medicinal Uses of Annonaceae.

Antibiotics Pharmacokine…0Antibiotics Pharmacokinetics and Efficacy: 0 fractional worksPain Mechanisms and Trea…0Pain Mechanisms and Treatments: 0 fractional worksPeripheral Neuropathies and Disorders: 0 fractional worksTraditional and Medicina…0Traditional and Medicinal Uses of Annonaceae: 0 fractional worksDrug Solubulity and Deli…0Drug Solubulity and Delivery Systems: 0 fractional worksNerve injury and regener…0Nerve injury and regeneration: 0 fractional worksAnalytical Methods in Ph…0Analytical Methods in Pharmaceuticals: 0 fractional worksSinusitis and nasal conditions: 0 fractional worksNeurotransmitter Receptor Influence on Behavior: 0 fractional worksCannabis and Cannabinoid Research: 0 fractional works
PharmacologyPhysiologyNeurologyBiochemistry4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Antibiotics Pharmacokinetics and Efficacy Pharmacology 0 works
  2. 2 Pain Mechanisms and Treatments Physiology 0 works
  3. 3 Peripheral Neuropathies and Disorders Neurology 0 works
  4. 4 Traditional and Medicinal Uses of Annonaceae Biochemistry 0 works
  5. 5 Drug Solubulity and Delivery Systems Pharmaceutical Science 0 works
  6. 6 Nerve injury and regeneration Cellular and Molecular Neuroscience 0 works
  7. 7 Analytical Methods in Pharmaceuticals Analytical Chemistry 0 works
  8. 8 Sinusitis and nasal conditions Otorhinolaryngology 0 works
  9. 9 Neurotransmitter Receptor Influence on Behavior Cellular and Molecular Neuroscience 0 works
  10. 10 Cannabis and Cannabinoid Research Pharmacology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available21.4%not open78.6%

World: 28% of research is openly available.

with international co-authors55.3%domestic only44.7%

World: 19% is written across borders.

How has Bionorica (Austria)'s research output changed?

Output in 2018–2022 was 58% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Innsbruck

All research institutions in Innsbruck

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.